As demand for life science centers continues growing, U.S. metros are avidly vying for life-science prominence, with Charleston, Columbus and Houston all emerging as fast-rising contenders.
Healthcare & Life Sciences Private Equity Deal Tracker: Northlane Capital Invests In Empower Community Care | Mcguirewoods Llp
Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care....By: McGuireWoods LLP. : Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care. Empower, based in Atlanta, is a behavioral health organization that distributes evidence-based programs and technologies. The company provides services in 45 states and 17 countries. Empower is the parent company of MST Services, Orbis Partners and Evidence Based Associates. NCP, based in Bethesda, Md., is a middle market private equity firm focused on healthcare and business services.
Healthcare & Life Sciences Private Equity Deal Tracker: Platinum Equity Acquires Ndc From Court Square Capital Partners | Mcguirewoods Llp
Platinum Equity has acquired NDC from an affiliate of Court Square Capital Partners, according to a news release....By: McGuireWoods LLP.
The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others.
Summary List PlacementTake all venture capital predictions with a grain of salt, Venrock partner Cami Samuel told Insider. Though Andreessen Horowitz may have predicted a flood of investment dollars in infectious diseases in 2021 inspired by the pandemic in its start-of-year blog post, the early-stage biotech VC is sticking to her guns. Last March, Samuels told TechCrunch that the pandemic likely wouldn't drastically increase investors' interest in infectious diseases. Almost a year later, Samuels told Insider her stance hasn't changed.
Neil Woodford has returned 16 months after the collapse of Woodford Investment Management with the launch of a new investment firm, which is working alongside Acacia Research to "advise" on an illiquid and unlisted portfolio of life sciences companies once owned by the Woodford Equity Income fund (WEIF).
Healthcare & Life Sciences Private Equity Deal Tracker: H.i.g. Capital Acquires Crothall Laundry Services | Mcguirewoods Llp
H.I.G. Capital has announced it has completed its acquisition of Crothall Laundry Services....By: McGuireWoods LLP. : Crothall Laundry Services is a provider of outsourced laundry and linen management services to the healthcare and hospitality markets. Founded in 1991, the company is formerly a Compass Group subsidiary. H.I.G. Capital, based in Miami, pursues a wide range of investments in healthcare and many other industries. Founded in 1993, the firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.
CAMBRIDGE, Mass., December 15, 2020-- nference, which synthesizes the world's biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC. "nference - a science-first software company - continues to push the boundaries of augmented intelligence to accelerate the work of our expert scientists and technologists in making biomedical knowledge computable via our nferXTM software platform," said Murali Aravamudan, co-founder and chief executive officer. "This funding enables expansion of our portfolio, which is catalyzing development of meaningful diagnostics and therapeutics.
Healthcare & Life Sciences Private Equity Deal Tracker: Serent Capital Invests In Procurement Partners | Mcguirewoods Llp
Serent Capital has completed a growth investment in Procurement Partners, according to a news release. Procurement Partners, based in Brookfield, Wis., is a provider of procure-to-pay solutions for healthcare providers....By: McGuireWoods LLP.
- Company optimizing lead compounds to file IND application and initiate first-in-human clinical trials targeting senescent cells in pulmonary disorders - Funding will be used to drive R&D, advance clinical pipeline and expand scientific team SUNNYVALE, Calif., December 3, 2020-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the closing of a $12M Seed financing round. The round was led by Khosla Ventures, with participation from Longevity Fund, Refactor Capital, Shanda and additional investors.